Four EU financial programmes provide funding for drug-related projects between 2014-2020, to help implement the objectives set by the EU Drugs Strategy 2013-2020 and to foster cross-border cooperation and research on drug issues.
The Justice Programme, which aims at contributing to the further development of a European area of justice, funds projects relating to drugs, in particular on policy coordination, judicial cooperation on drug-related issues, and new psychoactive substances. It has a budget of € 378 million.
The Internal Security Fund, which supports the implementation of the Internal Security Strategy, can provide funding for projects relating to drug supply. This includes cross-border cooperation against drug production and trafficking, and the development of innovative approaches to improve the understanding of drug markets and improve the effectiveness of drug law enforcement. It has a budget of around € 1 billion.
The Health Programme, whose objective is to promote health, prevent diseases and foster supportive environments for healthy lifestyles, will support health-related drug projects. It has a budget of € 449.4 million.
Horizon 2020 is the EU’s Research and Innovation programme, with a budget of nearly € 80 billion. Its ‘Health, demographic change and well-being’ component will provide funding to research relevant to drugs – for instance to develop innovative approaches to assess the risks of new drugs, to treat addiction and reduce the harms caused by drugs.
Currently there are no ongoing calls for this fund/programme.